Cargando…
IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity
C57BL/6 (B6) and B6 background STAT6(−/−) mice pretreated with IL-18 plus IL-2 showed prominent intestinal mastocytosis and rapidly expelled implanted adult worms of the gastrointestinal nematode Strongyloides venezuelensis. In contrast, identically pretreated mast cell–deficient W/W(v) mice failed...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212862/ https://www.ncbi.nlm.nih.gov/pubmed/16129701 http://dx.doi.org/10.1084/jem.20042202 |
_version_ | 1782148775131742208 |
---|---|
author | Sasaki, Yuki Yoshimoto, Tomohiro Maruyama, Haruhiko Tegoshi, Tatsuya Ohta, Nobuo Arizono, Naoki Nakanishi, Kenji |
author_facet | Sasaki, Yuki Yoshimoto, Tomohiro Maruyama, Haruhiko Tegoshi, Tatsuya Ohta, Nobuo Arizono, Naoki Nakanishi, Kenji |
author_sort | Sasaki, Yuki |
collection | PubMed |
description | C57BL/6 (B6) and B6 background STAT6(−/−) mice pretreated with IL-18 plus IL-2 showed prominent intestinal mastocytosis and rapidly expelled implanted adult worms of the gastrointestinal nematode Strongyloides venezuelensis. In contrast, identically pretreated mast cell–deficient W/W(v) mice failed to do so. Thus, activated mucosal mast cells (MMC) are crucial for parasite expulsion. B6 mice infected with S. venezuelensis third-stage larvae (L3) completed parasite expulsion by day 12 after infection, whereas IL-18(−/−) or IL-18Rα (−/−) B6 mice exhibited marked impairment in parasite expulsion, suggesting a substantial contribution of IL-18–dependent MMC activation to parasite expulsion. Compared with IL-18(−/−) or IL-18Rα (−/−) mice, S. venezuelensis L3–infected STAT6(−/−) mice have poorly activated MMC and sustained infection; although their IL-18 production is normal. Neutralization of IL-18 and IL-2 further reduces expulsion in infected STAT6(−/−) mice. These results suggest that collaboration between IL-18–dependent and Th2 cell–dependent mastocytosis is important for prompt parasite expulsion. |
format | Text |
id | pubmed-2212862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22128622008-03-11 IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity Sasaki, Yuki Yoshimoto, Tomohiro Maruyama, Haruhiko Tegoshi, Tatsuya Ohta, Nobuo Arizono, Naoki Nakanishi, Kenji J Exp Med Article C57BL/6 (B6) and B6 background STAT6(−/−) mice pretreated with IL-18 plus IL-2 showed prominent intestinal mastocytosis and rapidly expelled implanted adult worms of the gastrointestinal nematode Strongyloides venezuelensis. In contrast, identically pretreated mast cell–deficient W/W(v) mice failed to do so. Thus, activated mucosal mast cells (MMC) are crucial for parasite expulsion. B6 mice infected with S. venezuelensis third-stage larvae (L3) completed parasite expulsion by day 12 after infection, whereas IL-18(−/−) or IL-18Rα (−/−) B6 mice exhibited marked impairment in parasite expulsion, suggesting a substantial contribution of IL-18–dependent MMC activation to parasite expulsion. Compared with IL-18(−/−) or IL-18Rα (−/−) mice, S. venezuelensis L3–infected STAT6(−/−) mice have poorly activated MMC and sustained infection; although their IL-18 production is normal. Neutralization of IL-18 and IL-2 further reduces expulsion in infected STAT6(−/−) mice. These results suggest that collaboration between IL-18–dependent and Th2 cell–dependent mastocytosis is important for prompt parasite expulsion. The Rockefeller University Press 2005-09-05 /pmc/articles/PMC2212862/ /pubmed/16129701 http://dx.doi.org/10.1084/jem.20042202 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Sasaki, Yuki Yoshimoto, Tomohiro Maruyama, Haruhiko Tegoshi, Tatsuya Ohta, Nobuo Arizono, Naoki Nakanishi, Kenji IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title_full | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title_fullStr | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title_full_unstemmed | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title_short | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
title_sort | il-18 with il-2 protects against strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212862/ https://www.ncbi.nlm.nih.gov/pubmed/16129701 http://dx.doi.org/10.1084/jem.20042202 |
work_keys_str_mv | AT sasakiyuki il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT yoshimototomohiro il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT maruyamaharuhiko il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT tegoshitatsuya il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT ohtanobuo il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT arizononaoki il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity AT nakanishikenji il18withil2protectsagainststrongyloidesvenezuelensisinfectionbyactivatingmucosalmastcelldependenttype2innateimmunity |